Espen Njastein - PhotoCure ASA Insider

PHO -- Norway Stock  

NOK 33.30  1.30  4.06%

Mr. Espen Njastein was Head of Nordic Cancer Commercial Operations at Photocure ASA since January 2012. He was previously Nordic Cancer Commercial Operations Director at the Company since July 2010. He joined the Company in 2007 as Nordic Sales Manager. He has a degree in marketing from The Norwegian School of Marketing. Before joining Photocure, Espen Njastein has held different positions within sales and marketing at Pfizer. He came from a position as Training and Development Manager in Pfizer.
  Executive Since 2012      
47 22 06 22 10

Management Efficiency

The company has return on total asset (ROA) of (9.95) % which means that it has lost $9.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (13.68) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PhotoCure ASA operates under Drug Manufacturers - Major classification in Norway and traded on Oslo Stock Exchange. It employs 60 people.PhotoCure ASA (PHO) is traded on Oslo Stock Exchange in Norway. It is located in Hoffsveien 4 and employs 60 people.

PhotoCure ASA Leadership Team

Gwen Mellincoff, Director
Kathleen Deardorff, COO
Jan Egberts, Chairman of the Board
Jeremy Bahr, Chief Business Officer
Ambaw Bellete, Head of United States Cancer Commercial Operations
Grete Hogstad, Vice President of Strategic Marketing
Espen Njastein, Head of Nordic Cancer Commercial Operations
BenteLill Romoren, Chairman of the Board
Synne Roine, Director
Erik Dahl, CFO
Xavier Yon, Director
Johanna Holldack, Director
Lars Ronn, Director
Kjetil Hestdal, President CEO
Gry Stensrud, VP of Technical Devel. and Operations
Grannum Sant, Director
Inger Heglund, Vice President of Research and Development
Tom Pike, Director

Stock Performance Indicators

Did you try this?

Run Balance Of Power Now

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Balance Of Power
Currently Active Assets on Macroaxis
Purchased over 20 shares of
a day ago
Traded for 106.27
Purchased over 200 shares of
a day ago
Traded for 10.56
Purchased over 70 shares of
a day ago
Traded for 39.4
Purchased few shares of
a day ago
Traded for 1184.91
Purchased over 40 shares of
a day ago
Traded for 69.22
Additionally take a look at Your Equity Center. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.